Preclinical evaluation of combretastatin A4 phosphate: A drug which selectively damages tumor neovasculature

被引：0
|
作者：
Chaplin, DJ
Hill, SA
Pettit, GR
机构：
[1] Mt Vernon Hosp, Canc Res Trust, Gray Lab, Tumor Microcirculat Grp, Northwood HA6 2JR, Middx, England
[2] Arizona State Univ, Dept Chem, Tempe, AZ 85287 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
291
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Tumour neovasculature as a target for drug therapy: Studies with combretastatin A4 phosphate
    Hill, SA
    Galbraith, S
    Tozer, GM
    Dark, G
    Chaplin, DJ
    BRITISH JOURNAL OF CANCER, 1999, 80 : 91 - 91
  • [2] Combretastatin A4 phosphate
    Verdier-Pinard, P
    Lansiaux, A
    Bailly, C
    BULLETIN DU CANCER, 2001, 88 (03) : 235 - 239
  • [3] Combretastatin A4 phosphate
    West, CML
    Price, P
    ANTI-CANCER DRUGS, 2004, 15 (03) : 179 - 187
  • [4] Drug based approaches for targeting tumor vasculature: Development of combretastatin A4 phosphate
    Chaplin, DJ
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 : 9 - 10
  • [5] Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate
    Kirwan, IG
    Loadman, PM
    Swaine, DJ
    Anthoney, DA
    Pettit, GR
    Lippert, JW
    Shnyder, SD
    Cooper, PA
    Bibby, MC
    CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1446 - 1453
  • [6] Characterizing the tumor response to treatment with combretastatin A4 phosphate
    Salmon, Beth A.
    Siemann, Dietmar W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 211 - 217
  • [7] Tumor physiologic response to combretastatin A4 phosphate assessed by MRI
    Zhao, DW
    Jiang, L
    Hahn, EW
    Mason, RP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 872 - 880
  • [8] Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature
    Yang, Tingyuan
    Wang, Yiguang
    Li, Zaiquan
    Dai, Wenbing
    Yin, Jie
    Liang, Liang
    Ying, Xue
    Zhou, Shufeng
    Wang, Jiancheng
    Zhang, Xuan
    Zhang, Qiang
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (01) : 81 - 92
  • [9] The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability
    Beauregard, DA
    Hill, SA
    Chaplin, DJ
    Brindle, KM
    CANCER RESEARCH, 2001, 61 (18) : 6811 - 6815
  • [10] Combretastatin A4 phosphate (CA4P) selectively targets vasculature in animal and human tumors.
    Rustin, GJS
    Galbraith, SM
    Taylor, NJ
    Maxwell, R
    Tozer, G
    Baddeley, H
    Wilson, I
    Prise, V
    CLINICAL CANCER RESEARCH, 1999, 5 : 3732S - 3732S
12345